A class of type 2 diabetes drugs used to reduce blood sugar levels may actually promote the release of sugars into the blood, according to a paper published in the Journal of Biological Chemistry. The class of drugs is known as GLP-1 agonists, which includes the brand names Byetta (exenatide) and Victoza (liraglutide), which were made available in the United States in 2005 and 2010, respectively. According to Doctor Tipster, GLP-1 agonists work by imitating the effects of a naturally occurring hormone, called a glucagon-like peptide. This regulates blood sugar levels by stimulating the release of insulin and by inhibiting ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.